Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men

Clinical Endocrinology

Volumn 74, Issue 5, 2011, Pages 572-578

  Brand, Judith S ^a   Wareham, Nicholas J ^b   Dowsett, Mitch ^c   Folkerd, Elizabeth ^c   Van Der Schouw, Yvonne T ^a   Luben, Robert N ^d   Khaw, Kay Tee ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 79953765663     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03951.x     Document Type: Article

References (35)

1. Muller, M., van der Schouw, Y.T., Thijssen, J.H., et al. (2003) Endogenous sex hormones and cardiovascular disease in men. The Journal of Clinical Endocrinology and Metabolism, 88, 5076-5086. (Pubitemid 37452697)
2. Hak, A.E., Witteman, J.C., de Jong, F.H., et al. (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. The Journal of Clinical Endocrinology and Metabolism, 87, 3632-3639. (Pubitemid 34879505)
3. van den Beld, A.W., Bots, M.L., Janssen, J.A., et al. (2003) Endogenous hormones and carotid atherosclerosis in elderly men. American Journal of Epidemiology, 157, 25-31. (Pubitemid 36043733)
4. Khaw, K.T., Dowsett, M., Folkerd, E., et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation, 116, 2694-2701. (Pubitemid 350291241)
5. Yeap, B.B., Hyde, Z., Almeida, O.P., et al. (2009) Lower testosterone levels predict incident stroke and transient ischemic attack in older men. The Journal of Clinical Endocrinology and Metabolism, 94, 2353-2359.
6. Basaria, S., Coviello, A.D., Travison, T.G., et al. (2010) Adverse events associated with testosterone administration. The New England Journal of Medicine, 363, 109-122.
7. Laaksonen, D.E., Niskanen, L., Punnonen, K., et al. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. European Journal of Endocrinology, 149, 601-608. (Pubitemid 38054707)
8. Yeap, B.B., Chubb, S.A., Hyde, Z., et al. (2009) Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. European Journal of Endocrinology, 161, 591-598.
9. Yialamas, M.A., Dwyer, A.A., Hanley, E., et al. (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism, 92, 4254-4259. (Pubitemid 350074740)
10. Holmang, A., &, Bjorntorp, P., (1992) The effects of testosterone on insulin sensitivity in male rats. Acta Physiologica Scandinavica, 146, 505-510. (Pubitemid 23008349)
11. Khaw, K.T., Wareham, N., Bingham, S., et al. (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Annals of Internal Medicine, 141, 413-420.
12. Selvin, E., Steffes, M.W., Zhu, H., et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. The New England Journal of Medicine, 362, 800-811.
13. Day, N., Oakes, S., Luben, R., et al. (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. British Journal of Cancer, 80 (Suppl 1), 95-103. (Pubitemid 29389613)
14. Vermeulen, A., Verdonck, L., &, Kaufman, J.M., (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology and Metabolism, 84, 3666-3672. (Pubitemid 30645223)
15. Nieschlag, E., Swerdloff, R., Behre, H.M., et al. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male, 8, 56-58. (Pubitemid 40978894)
16. Wareham, N.J., Jakes, R.W., Rennie, K.L., et al. (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutrition, 6, 407-413. (Pubitemid 36749764)
17. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Suppl 1), S62-S69.
18. Ding, E.L., Song, Y., Malik, V.S., et al. (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 295, 1288-1299.
19. Tang, Y.J., Lee, W.J., Chen, Y.T., et al. (2007) Serum testosterone level and related metabolic factors in men over 70 years old. Journal of Endocrinological Investigation, 30, 451-458.
20. Fernandez-Real, J.M., Grasa, M., Casamitjana, R., et al. (1999) Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. The Journal of Clinical Endocrinology and Metabolism, 84, 3192-3196. (Pubitemid 30646943)
21. El-Sakka, A.I., Sayed, H.M., &, Tayeb, K.A., (2008) Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. International Journal of Andrology, 31, 602-608.
22. Svartberg, J., Jenssen, T., Sundsfjord, J., et al. (2004) The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromso Study. Diabetes and Metabolism, 30, 29-34. (Pubitemid 38418940)
23. Barrett-Connor, E., Khaw, K.T., &, Yen, S.S., (1990) Endogenous sex hormone levels in older adult men with diabetes mellitus. American Journal of Epidemiology, 132, 895-901. (Pubitemid 20363668)
24. Suzuki, R., Allen, N.E., Appleby, P.N., et al. (2009) Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes and Control, 20, 811-821.
25. Ding, E.L., Song, Y., Manson, J.E., et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. The New England Journal of Medicine, 361, 1152-1163.
26. Li, C., Ford, E.S., Li, B., et al. (2010) Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care, 33, 1618-1624.
27. Perry, J.R., Weedon, M.N., Langenberg, C., et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Human Molecular Genetics, 19, 535-544.
28. Lakshman, K.M., Bhasin, S., &, Araujo, A.B., (2010) Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 65, 503-509.
29. Rajala, U.M., Keinanen-Kiukaanniemi, S.M., Hirsso, P.K., et al. (2007) Associations of total testosterone and sex hormone-binding globulin levels with insulin sensitivity in middle-aged Finnish men. Diabetes Care, 30, e13. (Pubitemid 46556615)
30. Cameron, D.F., Rountree, J., Schultz, R.E., et al. (1990) Sustained hyperglycemia results in testicular dysfunction and reduced fertility potential in BBWOR diabetic rats. The American Journal of Physiology, 259, E881-E889.
31. Astort, F., Repetto, E.M., Martinez Calejman, C., et al. (2009) High glucose-induced changes in steroid production in adrenal cells. Diabetes Metabolism Research and Reviews, 25, 477-486.
32. Kapoor, D., Goodwin, E., Channer, K.S., et al. (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 154, 899-906. (Pubitemid 43997730)
33. Heufelder, A.E., Saad, F., Bunck, M.C., et al. (2009) Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. Journal of Andrology, 30, 726-733.
34. Emmelot-Vonk, M.H., Verhaar, H.J., Nakhai Pour, H.R., et al. (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA, 299, 39-52.
35. Selva, D.M., Hogeveen, K.N., Innis, S.M., et al. (2007) Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. The Journal of Clinical Investigation, 117, 3979-3987. (Pubitemid 350224107)